IP-LAD

Chemical compound From Wikipedia, the free encyclopedia

IP-LAD, or IPLAD, also known as IPR-LAD or as 6-isopropyl-6-nor-LSD, is an analogue of lysergic acid diethylamide (LSD) developed by the team of David E. Nichols.[1][2] In studies on mice, it was found to be approximately 40% the potency of LSD, compared to the 60% increase in potency seen with ETH-LAD, 2-fold potency increase of AL-LAD, and roughly equivalent potency of PRO-LAD.[2] It is not a controlled substance in Canada as of 2025.[3]

Other namesIPRLAD; IP-LAD; IPLAD; 6-Isopropyl-6-nor-LSD; 6-Isopropyl-6-nor-lysergic acid diethylamide
Routes of
administrationOral
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Quick facts Clinical data, Other names ...
IP-LAD
Clinical data
Other namesIPRLAD; IP-LAD; IPLAD; 6-Isopropyl-6-nor-LSD; 6-Isopropyl-6-nor-lysergic acid diethylamide
Routes of
administration		Oral
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class A
Identifiers
  • (6aR,9R)-N,N-Diethyl-7-propan-2-yl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC22H29N3O
Molar mass351.494 g·mol−1
3D model (JSmol)
  • CCN(CC)C(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C(C)C
  • InChI=1S/C22H29N3O/c1-5-24(6-2)22(26)16-10-18-17-8-7-9-19-21(17)15(12-23-19)11-20(18)25(13-16)14(3)4/h7-10,12,14,16,20,23H,5-6,11,13H2,1-4H3/t16-,20-/m1/s1
  • Key:GLNOSFGSNDKLOC-OXQOHEQNSA-N
  (verify)
Close

See also

References

External links

Related Articles

Wikiwand AI